11-68312746-CGCTGCTGCT-C
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_002335.4(LRP5):βc.52_60delβ(p.Leu18_Leu20del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.013 in 1,061,146 control chromosomes in the GnomAD database, including 75 homozygotes. Variant has been reported in ClinVar as Likely benign (β β ).
Frequency
Genomes: π 0.0090 ( 5 hom., cov: 28)
Exomes π: 0.014 ( 70 hom. )
Consequence
LRP5
NM_002335.4 inframe_deletion
NM_002335.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.190
Genes affected
LRP5 (HGNC:6697): (LDL receptor related protein 5) This gene encodes a transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis. This protein also acts as a co-receptor with Frizzled protein family members for transducing signals by Wnt proteins and was originally cloned on the basis of its association with type 1 diabetes mellitus in humans. This protein plays a key role in skeletal homeostasis and many bone density related diseases are caused by mutations in this gene. Mutations in this gene also cause familial exudative vitreoretinopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 11-68312746-CGCTGCTGCT-C is Benign according to our data. Variant chr11-68312746-CGCTGCTGCT-C is described in ClinVar as [Likely_benign]. Clinvar id is 204504.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-68312746-CGCTGCTGCT-C is described in Lovd as [Benign]. Variant chr11-68312746-CGCTGCTGCT-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00902 (1303/144404) while in subpopulation NFE AF= 0.0137 (894/65172). AF 95% confidence interval is 0.013. There are 5 homozygotes in gnomad4. There are 584 alleles in male gnomad4 subpopulation. Median coverage is 28. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 SD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRP5 | NM_002335.4 | c.52_60del | p.Leu18_Leu20del | inframe_deletion | 1/23 | ENST00000294304.12 | NP_002326.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRP5 | ENST00000294304.12 | c.52_60del | p.Leu18_Leu20del | inframe_deletion | 1/23 | 1 | NM_002335.4 | ENSP00000294304 | P1 | |
LRP5 | ENST00000529993.5 | c.52_60del | p.Leu18_Leu20del | inframe_deletion, NMD_transcript_variant | 1/23 | 1 | ENSP00000436652 |
Frequencies
GnomAD3 genomes AF: 0.00901 AC: 1300AN: 144318Hom.: 5 Cov.: 28
GnomAD3 genomes
AF:
AC:
1300
AN:
144318
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000491 AC: 8AN: 16308Hom.: 0 AF XY: 0.000812 AC XY: 8AN XY: 9856
GnomAD3 exomes
AF:
AC:
8
AN:
16308
Hom.:
AF XY:
AC XY:
8
AN XY:
9856
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0137 AC: 12529AN: 916742Hom.: 70 AF XY: 0.0134 AC XY: 5870AN XY: 438388
GnomAD4 exome
AF:
AC:
12529
AN:
916742
Hom.:
AF XY:
AC XY:
5870
AN XY:
438388
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00902 AC: 1303AN: 144404Hom.: 5 Cov.: 28 AF XY: 0.00831 AC XY: 584AN XY: 70312
GnomAD4 genome
AF:
AC:
1303
AN:
144404
Hom.:
Cov.:
28
AF XY:
AC XY:
584
AN XY:
70312
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:5
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | LRP5: BS1 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 08, 2019 | This variant is associated with the following publications: (PMID: 21151595, 12579474, 16234968, 19177549) - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Autosomal dominant polycystic liver disease Uncertain:1
Uncertain significance, no assertion criteria provided | research | Laboratory of Gastroenterology and Hepatology, Radboud University Medical Center | Sep 01, 2021 | - - |
Osteogenesis imperfecta Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Mar 21, 2022 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 16, 2017 | - - |
Increased bone mineral density Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Mar 21, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at